Cmh Wealth Management LLC Biomarin Pharmaceutical Inc Transaction History

Cmh Wealth Management LLC

$423 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$86.68 - $100.3 $83,559 - $96,689	964 Added 3.56%	28,049 $2.43 Million
Q1 2023 Apr 10, 2023	SELL	$87.74 - $117.27 $1.31 Million - $1.75 Million	-14,884 Reduced 35.46%	27,085 $2.63 Million
Q4 2022 Jan 12, 2023	SELL	$80.93 - $108.63 $17,399 - $23,355	-215 Reduced 0.51%	41,969 $0
Q3 2022 Oct 24, 2022	SELL	$82.16 - $96.94 $79,448 - $93,740	-967 Reduced 2.24%	42,184 $3.58 Million
Q2 2022 Jul 15, 2022	BUY	$71.48 - $86.85 $118,942 - $144,518	1,664 Added 4.01%	43,151 $3.58 Million
Q1 2022 Apr 13, 2022	BUY	$74.28 - $92.69 $290,509 - $362,510	3,911 Added 10.41%	41,487 $3.2 Million
Q4 2021 Jan 18, 2022	SELL	$71.72 - $91.47 $6,096 - $7,774	-85 Reduced 0.23%	37,576 $3.32 Million
Q3 2021 Oct 18, 2021	BUY	$74.77 - $85.47 $129,725 - $148,290	1,735 Added 4.83%	37,661 $2.91 Million
Q2 2021 Jul 19, 2021	BUY	$75.51 - $84.79 $146,036 - $163,983	1,934 Added 5.69%	35,926 $3 Million
Q1 2021 Apr 19, 2021	BUY	$74.73 - $90.69 $65,687 - $79,716	879 Added 2.65%	33,992 $2.57 Million
Q4 2020 Feb 01, 2021	BUY	$72.61 - $90.2 $574,054 - $713,121	7,906 Added 31.36%	33,113 $2.9 Million
Q3 2020 Oct 20, 2020	BUY	$71.87 - $131.03 $269,584 - $491,493	3,751 Added 17.48%	25,207 $1.92 Million
Q2 2020 Jul 23, 2020	SELL	$79.55 - $124.22 $128,791 - $201,112	-1,619 Reduced 7.02%	21,456 $2.65 Million
Q1 2020 Apr 16, 2020	BUY	$71.37 - $96.85 $92,424 - $125,420	1,295 Added 5.95%	23,075 $1.95 Million
Q4 2019 Jan 21, 2020	SELL	$64.27 - $86.37 $1.41 Million - $1.89 Million	-21,930 Reduced 50.17%	21,780 $1.84 Million
Q3 2019 Oct 11, 2019	BUY	$67.4 - $85.11 $1.1 Million - $1.39 Million	16,342 Added 59.71%	43,710 $2.95 Million
Q2 2019 Jul 15, 2019	BUY	$80.35 - $93.9 $6,829 - $7,981	85 Added 0.31%	27,368 $2.34 Million
Q1 2019 Apr 15, 2019	BUY	$84.2 - $98.62 $1.18 Million - $1.38 Million	14,010 Added 105.55%	27,283 $2.42 Million
Q4 2018 Jan 16, 2019	BUY	$80.14 - $106.07 $4,007 - $5,303	50 Added 0.38%	13,273 $1.13 Million
Q3 2018 Oct 29, 2018	BUY	$93.92 - $105.72 $148,863 - $167,566	1,585 Added 13.62%	13,223 $1.3 Million
Q2 2018 Jul 20, 2018	SELL	$76.01 - $99.03 $1,900 - $2,475	-25 Reduced 0.21%	11,638 $1.09 Million
Q1 2018 Apr 11, 2018	SELL	$77.67 - $92.63 $759,224 - $905,458	-9,775 Reduced 45.6%	11,663 $901,000
Q4 2017 Jan 12, 2018	SELL	$80.76 - $95.13 $3,634 - $4,280	-45 Reduced 0.21%	21,438 $1.95 Million
Q3 2017 Oct 19, 2017	BUY	$80.6 - $94.95 $1.73 Million - $2.04 Million	21,483	21,483 $2.01 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cmh Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cmh Wealth Management LLC with notifications on news.

Account